NURSING IN THE ERA OF BIOTERRORISM Definition of Bioterrorism Premeditated threat or actual use of biological weapons to produce disease or death in people, animals, or plants. Biological weapons: microbes or their toxins. Biological Weapons Bioterrorism Overview Microorganisms or their toxins can be in liquid or powder form. Various delivery methods are possible: aerosol envelope or package food or water contamination Exposure can be isolated to a single area or can be more widespread. Bioterrorism Microorganisms as biologic weapons would most likely result in illness occurring days to weeks after attack and would affect persons dispersed from the site. Biological Agents: Types and Characteristics Bacteria Viruses Biological Toxins CDC Categories Category A: easily disseminated OR transmitted person to person susceptible population potential for panic / disruption requires special action for treatment high morbidity and mortality examples: anthrax, smallpox, plague, botulism, viral hemorrhagic fevers CDC Categories Category B: moderately easy to disseminate moderate morbidity, low mortality examples: Q fever, brucellosis, glanders, some toxins Category C: emerging pathogens that could be engineered for mass dissemination in the future potential for high morbidity and mortality examples: hantavirus, tickborne viruses, MDR TB Isolation Precautions Standard (“blood and body fluid”): gloves mask with face shield gown Airborne: standard plus negative pressure room and N95 mask (“duckbill mask”) Creating an Epidemic/Pandemic How microorganisms spread across a country USA WNV Anthrax: Overview Gram positive bacillus that forms spores Spores found in soil worldwide Humans usually infected by contact with infected animals or contaminated animal products No person-to-person transmission of inhalation anthrax Anthrax: Cutaneous Most common form (95%) Inoculation of spores in skin Incubation: hours to days Progression: 1. small papule 2. ulcer surrounded by vesicles 3. painless eschar with edema Death: • • untreated – 20% treated – rare 2.2 KG’S OF ANTHRAX SPRINKLED FROM A 20TH FLOOR HIGH RISE IN NEW YORK CITY WOULD KILL / INFECT OVER 120,000 PEOPLE Plague: Overview Yersinia pestis (gram-negative coccobacillus) About 10 U.S. cases/yr (SW) Two major forms Very contagious via respiratory droplets Plague Epidemics 3 major recorded epidemics: 550, 1350 (Black Death), 1850 (China) 30% - 60% mortality in infected continents Plague GOOD NEWS: future epidemics unlikely due to sanitation, public health practices, and antibiotics. BAD NEWS: US and Russia and other countries have developed techniques to aerosolize plague, eliminating need for fleas to spread the infection. Plague as a Bioweapon Infected fleas could spread bubonic form (less likely scenario) Aerosolized organisms would spread pneumonic form (more likely scenario) Plague: Bubonic Bite from infected flea Sudden onset flu-like syndrome Buboes: tender, enlarged lymph nodes (inguinal, axillary, cervical) Can spread to lungs (hematogenous) Can also lead to endotoxic septicemic phase Plague: Pneumonic Inhalation of organisms (aerosol) Incubation: 1-3 days Sudden onset flu-like syndrome Pneumonia progresses rapidly to hypoxemia, cyanosis, hemoptysis Endotoxin: septic shock with DIC, ARDS, death Pneumonic Plague: Isolation precautions SECONDARY TRANSMISSION IS POSSIBLE - EASILY USE STANDARD AND AIRBORNE PRECAUTIONS Viruses as Bioweapons Viral Hemorrhagic Fevers: Ebola Lassa Marburg Smallpox Viral Hemorrhagic Fevers Group of illnesses caused by several RNA viruses All can be used as bioweapons Examples: Ebola, Marburg, Lassa Mortality can be very high (90% for Ebola) VHF: Occurrence Naturally occurring infections can occur via transmission from infected rodents and arthropods Readily transmissible from person to person via body fluids: great risk for healthcare workers VHF very rare in US: usually travelers to endemic areas CURRENT OUTBREAK Current outbreak in Africa (since Dec 2013) 80-89% MORTALITY Usually (this one is about 60%) VHF: Pathophysiology Variable incubation (2-21 days) Flu-like symptoms with high fever Increased vascular permeability causes: hemorrhage in GI tract and mucous membranes petechial or ecchymotic rash edema hypotension Rapid progression to shock and death VHF: Treatment Supportive treatment IV ribavirin used occasionally for Lassa fever. Vaccines under development (FDA approved experimental use for W African outbreak) Postexposure prophylaxis with oral ribavirin may be useful Contact and respiratory precautions necessary Smallpox Variola virus Characteristic skin lesions About 30% mortality in unvaccinated Last known natural case: Somalia in 1977 Smallpox as a Bioweapon Can be aerosolized Highly contagious No effective treatment Vaccination ceased in 70’s Stable in the environment (contamination for months) Smallpox: Pathophysiology Virus inhaled or deposited on mucous membranes Goes to lymph nodes, incubates for 7-17 days Release into blood causes flu-like symptoms Rash begins 2-3 days later Death due to toxemia of viral antigens and circulating immune complexes Smallpox: Skin lesions Macular (flat, red) rash 2-3 days after flu symptoms Starts on face, forearms, hands (+ palms and soles) Rash evolves synchronously in an area Evolves into tense vesicles Scabs form in 7-10 days if patient lives Infectious until all scabs are shed. Day 3 Day 5 Day 7 Chickenpox with characteristic rose-colored macules, papules, vesicles, pustules, necrotic pustules, and crusted lesions occurring simultaneously. Herpes zoster showing dermatomal distribution of lesions Herpes zoster (varicella virus) with characteristic grouping of vesicles Smallpox vs. Chickenpox Smallpox Chickenpox Prodrome yes minimal or none Distribution out to in in to out Lesions Progression Palms / Soles painful / deep synchronous yes pruritic / superficial asynchronous no Smallpox vs. Chickenpox Smallpox: Precautions Airborne and Contact Isolation Airborne Isolation: negative pressure room anteroom closed ventilation system N95 mask (Duckbill mask) Contact Isolation: strict use of PPE and handwashing BIOLOGICAL TOXINS BOTULINUM – BO-TOX RICIN STAPHYLOOCCAL ENTEROTOXIN B (not reviewed) RICIN T-2 MYCOTOXINS (not reviewed) Botulinum Toxin 7 neurotoxins produced by Clostridium botulinum Among the most toxic substances known May be found in naturally contaminated food As a bioweapon, likely to be delivered by aerosol No person-to-person transmission Multiple cases without common food source suggests bioterrorism Ricin Potent protein toxin derived from castor beans Easily produced / Recently found in France Inhibits protein synthesis Causes necrotizing airway lesions: tracheitis bronchitis and bronchiolitis interstitial pneumonia with ARDS Ricin Inhalation as an aerosol produces severe respiratory symptoms: day 1: cough, fever, dyspnea day 2-3: pulmonary edema, resp failure, death Specific serum test is available No treatment available other than supportive Chemical Weapons Nerve agents Vessicants (blistering agents) Pulmonary agents Blood agents (cyanide) Riot Control agents Nerve Agents Most toxic of all the synthetic chemical agents. Very similar to organophosphate insecticides. Death within minutes when inhaled or absorbed through skin. Developed in WW2 by Germany but not used. U.S. completed development after WW2. Examples: SARIN Nerve Agents: Effects Smooth muscle hyper stimulation Glandular hyper stimulation Skeletal muscle hyper stimulation Nerve Agents: Effects Smooth muscle hyper stimulation: vomiting and diarrhea urination bronchospasm small pupils (miosis) Nerve Agents: Effects Glandular hyper stimulation: salivation lacrimation increased airway secretions increased GI secretions Nerve Agents: Effects Skeletal muscle hyper stimulation at first: Fasciculations Later, skeletal muscle exhaustion: weakness followed by flaccid paralysis Nerve Agents: Effects SLUDGE reaction: Salivation Lacrimation Urination Defecation Generalized twitching Emesis Nerve Agents: Decontamination Removal of contaminated clothing Copious irrigation and washing with soap and water BIOSUITS- NO CONTACT WITH AGENT Sources of Radioactive Material High-level sources (plutonium, uranium): nuclear power plants and weapons sites high security; more difficult to obtain and handle Low-level sources (cobalt-60, strontium-90, cesium-137, americium-241): hospitals construction sites food irradiation plants smoke detectors Bombing Frequency Worldwide, 50% of terrorist attacks are bombings. In U.S., over 85% of terrorist attacks are bombings.